FX and host defense evasion tactics by adenovirus.
作者信息
Baker Andrew H, Nicklin Stuart A, Shayakhmetov Dmitry M
机构信息
Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
出版信息
Mol Ther. 2013 Jun;21(6):1109-11. doi: 10.1038/mt.2013.100.
Abstract
摘要
相似文献
1
FX and host defense evasion tactics by adenovirus.腺病毒的FX与宿主防御规避策略
Mol Ther. 2013 Jun;21(6):1109-11. doi: 10.1038/mt.2013.100.
2
Coagulation factor defends adenovirus from immune attack.凝血因子保护腺病毒免受免疫攻击。
Nat Med. 2013 Apr;19(4):406-7. doi: 10.1038/nm.3149.
3
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.凝血因子 X 可保护 5 型腺病毒免受天然抗体和补体的攻击。
Nat Med. 2013 Apr;19(4):452-7. doi: 10.1038/nm.3107. Epub 2013 Mar 24.
4
Occurrence and significance of adenovirus antibody in sera of recruit and cadre military personnel.新兵和军队干部血清中腺病毒抗体的发生情况及意义
Am J Hyg. 1958 Mar;67(2):179-86. doi: 10.1093/oxfordjournals.aje.a119926.
5
Coagulation factor X activates innate immunity to human species C adenovirus.凝血因子 X 激活人体 C 型腺病毒固有免疫。
Science. 2012 Nov 9;338(6108):795-8. doi: 10.1126/science.1226625. Epub 2012 Sep 27.
6
Letter: Experimental infection of a horse with an equine adenovirus.信件：一匹马感染马腺病毒的实验性感染。
Aust Vet J. 1974 Jun;50(6):278-9. doi: 10.1111/j.1751-0813.1974.tb05306.x.
7
Adenovirus-associated virus-precipitating antibody as an early indicator of an adenovirus infection.腺病毒相关病毒沉淀抗体作为腺病毒感染的早期指标。
Am J Vet Res. 1979 Feb;40(2):277-9.
8
Microprecipitation test for the detection of adenovirus antibody.用于检测腺病毒抗体的微量沉淀试验。
Life Sci. 1974 Jul 1;15(1):37-44. doi: 10.1016/0024-3205(74)90191-x.
9
[Anti-adenovirus humoral immunity: impact on dendritic cell activation].[抗腺病毒体液免疫：对树突状细胞激活的影响]
Med Sci (Paris). 2017 Jun-Jul;33(6-7):582-585. doi: 10.1051/medsci/20173306008. Epub 2017 Jul 19.
10
Mesangial localization of immune complexes in experimental canine adenovirus glomerulonephritis.实验性犬腺病毒肾小球肾炎中免疫复合物的系膜定位。
Br J Exp Pathol. 1974 Oct;55(5):458-65.
引用本文的文献
1
Dendritic cell targeting in lymph nodes with modular adapters boosts HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21.使用模块化衔接子靶向淋巴结中的树突状细胞，通过共分泌IL-2v和IL-21增强腺病毒5型和HC-腺病毒5型肿瘤疫苗接种效果。
Mol Ther Oncol. 2025 Apr 14;33(2):200984. doi: 10.1016/j.omton.2025.200984. eCollection 2025 Jun 18.
2
Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors.通过间充质基质细胞递送溶瘤病毒进行免疫治疗以治疗转移性肿瘤。
Mol Ther Oncolytics. 2022 Mar 19;25:78-97. doi: 10.1016/j.omto.2022.03.008. eCollection 2022 Jun 16.
3
Optimizing Active Tumor Targeting Biocompatible Polymers for Efficient Systemic Delivery of Adenovirus.优化主动靶向肿瘤的生物相容性聚合物以实现腺病毒的高效系统递送。
Cells. 2021 Jul 26;10(8):1896. doi: 10.3390/cells10081896.
4
The superior role of coagulation factor FX over FVII in adenoviral-mediated innate immune induction of the hepatocyte: an experiment.凝血因子FX在腺病毒介导的肝细胞固有免疫诱导中比FVII具有更重要的作用：一项实验。
Clin Exp Hepatol. 2020 Sep;6(3):199-206. doi: 10.5114/ceh.2020.99512. Epub 2020 Sep 30.
5
Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors.六邻体高变区修饰的5型腺病毒（Ad5）载体显示出较低的肝毒性，但诱导出与Ad5载体相似的T淋巴细胞表型。
Clin Vaccine Immunol. 2014 Aug;21(8):1137-44. doi: 10.1128/CVI.00207-14. Epub 2014 Jun 18.
6
Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer.人全长凝血因子X和一个源自GLA结构域的40聚体多肽与5型腺病毒六邻体 capsomer的不同区域结合。
Hum Gene Ther. 2014 Apr;25(4):339-49. doi: 10.1089/hum.2013.222. Epub 2014 Mar 25.
7
Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo.无痕迹生物响应性遮蔽腺病毒六邻体与 HPMA 共聚物在体外和体内保持转导能力。
PLoS One. 2014 Jan 27;9(1):e82716. doi: 10.1371/journal.pone.0082716. eCollection 2014.
本文引用的文献
1
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.凝血因子 X 可保护 5 型腺病毒免受天然抗体和补体的攻击。
Nat Med. 2013 Apr;19(4):452-7. doi: 10.1038/nm.3107. Epub 2013 Mar 24.
2
Coagulation factor X activates innate immunity to human species C adenovirus.凝血因子 X 激活人体 C 型腺病毒固有免疫。
Science. 2012 Nov 9;338(6108):795-8. doi: 10.1126/science.1226625. Epub 2012 Sep 27.
3
Natural IgM mediates complement-dependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum.天然 IgM 通过补体受体 1 和 3 介导非免疫血清中弗氏志贺菌属的补体依赖性人中性粒细胞摄取。
J Immunol. 2012 Sep 15;189(6):3064-77. doi: 10.4049/jimmunol.1200816. Epub 2012 Aug 10.
4
Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses.新型五型腺病毒五重和六重突变衣壳蛋白的体内分布和炎症特征。
J Control Release. 2012 Dec 28;164(3):394-402. doi: 10.1016/j.jconrel.2012.05.025. Epub 2012 May 22.
5
Tropism-modification strategies for targeted gene delivery using adenoviral vectors.利用腺病毒载体进行靶向基因传递的嗜性修饰策略。
Viruses. 2010 Oct;2(10):2290-2355. doi: 10.3390/v2102290. Epub 2010 Oct 13.
6
A cluster of basic amino acids in the factor X serine protease mediates surface attachment of adenovirus/FX complexes.因子 X 丝氨酸蛋白酶中的一簇碱性氨基酸介导腺病毒/FX 复合物的表面附着。
J Virol. 2011 Oct;85(20):10914-9. doi: 10.1128/JVI.05382-11. Epub 2011 Aug 17.
7
Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus).凝血因子 X 介导 5 型腺病毒在非人类灵长类动物（小家鼠）肝脏中的基因转移。
Gene Ther. 2012 Jan;19(1):109-13. doi: 10.1038/gt.2011.87. Epub 2011 Jun 16.
8
Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X.腺病毒与凝血因子 X 复合物感染过程中受体结合的要求。
PLoS Pathog. 2010 Oct 7;6(10):e1001142. doi: 10.1371/journal.ppat.1001142.
9
Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.FX 结合缺失的腺病毒血清型 5 载体的生物分布和重定向。
Blood. 2010 Oct 14;116(15):2656-64. doi: 10.1182/blood-2009-12-260026. Epub 2010 Jul 7.
10
Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus.六邻体修饰的溶瘤腺病毒扩大了抗癌治疗窗口。
Mol Ther. 2009 Dec;17(12):2121-30. doi: 10.1038/mt.2009.217. Epub 2009 Sep 15.
Zotero 插件